###### Strengths and limitations of this study

-   This is a cross-sectional retrospective review of a large sample of critically ill children cared for in a predominantly neonatal intensive care unit.

-   The study adds information about the outcome of critically ill children in sub-Saharan Africa.

-   Predictors of mortality are reported for different age categories.

-   Severity of illness scoring was not available during the study period, so only unadjusted mortality rates are reported.

-   This was a retrospective analysis of a computerised database, so not all records were available for inclusion.

Background {#s1}
==========

The WHO reports that 5.9 million children under the age of 5 years died in 2015, 75% of whom were infants (under the age of 1 year), and most infants who died were from the WHO African region.[@R1] The outcome of critically ill children may be improved by adequate intensive care. Provision of paediatric and neonatal intensive care in a low-to-middle-income country (LMIC) is challenging.[@R2] Difficulties include lack of medical and nursing staff, insufficient medication and equipment and inadequate diagnostic facilities.[@R2] [@R3] Identifying the optimal use of paediatric intensive care unit (PICU) beds in a resource-limited situation is difficult. The ICU admission criteria attempt to ensure that the limited facilities benefit those who will gain most; children without a reasonable chance of functional recovery are not routinely admitted to PICU.[@R2] [@R4] Argent *et al*[@R4] discussed an approach to optimising the use of limited PICU facilities at the Red Cross War Memorial Children\'s Hospital (RCWMCH) in Cape Town, South Africa, stating that hospitals need to develop 'explicit policies for utilisation of PICU resources' using 'a reasonable process for fair and equitable utilisation of scarce resources... that may extend beyond the priorities of individual patients'.

Mortality and infection rates in PICU in developing countries are influenced by the income level of the country.[@R5] The average PICU mortality rate in Latin American countries was 13.39% compared with 5.4% in European countries.[@R6] The mean PICU mortality rate in Turkey was reported to be 14.6%.[@R3] PICU mortality at the RCWMCH in Cape Town, however, has declined from 10.6% in 2006 to 9% in 2010.[@R4] [@R7] The mortality rate of children admitted to general ICU facilities in other African countries is far higher than the RCWMCH experience, ranging from 36% to 40%.[@R8]

Children admitted to a centralised dedicated paediatric ICU have better survival rates than those treated in general or shared ICU facilities, even in developing countries.[@R11] [@R12] Dedicated PICU facilities are uncommon in South Africa. Critical care beds in South Africa are concentrated in the more affluent provinces (Gauteng, KwaZulu-Natal and the Western Cape) and in the private sector.[@R13] [@R14] Only 19.6% of the total ICU beds were for paediatric and neonatal intensive care, and mixed surgical and medical units admit children in most hospitals.[@R13] Lack of dedicated PICU facilities is common in many other African countries. In Uganda, for example, there is one general ICU bed per million people.[@R10]

Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) is a quaternary referral hospital with a single combined paediatric/neonatal ICU (PNICU) with 14 ventilator beds. This unit serves neonates, general paediatrics, paediatric subspecialities and paediatric surgery; renal dialysis and high-frequency ventilation are available. The age of admission ranges from birth to 14 years. It is often not possible to admit patients because of a lack of available beds. The unit has no dedicated paediatric intensivist but is run by other subspecialists, mainly neonatologists. Nasal continuous positive airway pressure (NCPAP) is the first line of ventilatory support for neonates with respiratory failure.[@R15] Patients who require 'high-care' observation or treatment are not routinely admitted; the PNICU essentially functions as a ventilator unit. Additional information regarding the CMJAH PNICU is provided in the online [supplementary material file](#SM1){ref-type="supplementary-material"}, available online. There is a lack of information on admissions to the CMJAH PNICU. This study therefore aimed to review the survival to discharge of patients admitted to the unit. Secondary objectives included comparing the survival rate between paediatric and neonatal patients, determining the disease profile of patients and establishing predictors or factors associated with poor survival.
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Patients and methods {#s2}
====================

This was a retrospective cross-sectional record review of all patients admitted to the CMJAH PNICU between 1 January 2013 and 30 June 2015. The PNICU admitted neonates and older children who suffered from medical or surgical conditions. Patients were admitted and cared for at the discretion of the attending physician, using age-related norms and treatment protocols. Owing to limited availability of PNICU beds, patients with an anticipated poor outcome, including those with advanced HIV-related disease, were not routinely ventilated. Similarly, neonates below 900 g birth weight were not usually offered mechanical ventilation. Exposure to HIV alone was not a reason for exclusion from PNICU.

Patient charts were reviewed on discharge from PNICU, and demographic, clinical and outcome data were captured. Variables were recorded as positive if there had been any occurrence during their time in the PNICU. Detailed definitions of the variables used in the study are provided in the online [supplementary file](#SM1){ref-type="supplementary-material"}, available online.

Patient data were entered into computerised databases for clinical audit and quality improvement. These databases are managed by Research Electronic Data Capture (REDCap) hosted by the University of the Witwatersrand.[@R16] The data were deidentified and entered into IBM SPSS (V.22) for the purposes of analysis. Patients with no retrievable information were excluded from the study.

Definitions of patient categories {#s2a}
---------------------------------

The group of patients was divided into paediatric patients (\>28 days of age) and neonates. Neonates were classified as those \<28 days of age who had never been discharged home, and who had been admitted directly to PNICU from other hospitals or the neonatal nursery at CMJAH. Neonates who had been discharged home and then readmitted to PNICU were classified as paediatric patients. Neonates were further divided into very low birthweight (VLBW) infants (\<1500 g birth weight) and bigger babies ([\>]{.ul}1500 g birth weight). Children older than 14 years were usually admitted to the adult ICU. All neonates admitted to PNICU in this study were intubated and ventilated; some paediatric patients were not intubated but admitted for high-care treatment.

Surgical patients were defined as all children who presented with a surgical condition. Postoperative admissions defined those surgical patients who were electively admitted to PNICU post surgery.

Statistical analysis {#s2b}
--------------------

Continuous variables such as age at admission were described using mean and SD or median with IQR, depending on whether the data were normally distributed. Categorical variables were described as frequencies and percentages. Survival to discharge from ICU was considered the primary outcome variable for comparison.

Univariate analysis comparing different characteristics between survivors and non-survivors used an independent t-test for normally distributed data and the Mann-Whitney U test for skewed data. A χ^2^ test was used to compare differences in survival for categorical variables. A p value of \<0.05 was considered to be statistically significant. Variables with a p value \<0.05 in the univariate analysis were entered into a multiple stepwise logistic regression model to establish determinants of survival to PNICU discharge. Neonates and older paediatric patients have different disease profiles and different risk factors for mortality. Data were therefore analysed separately for VLBW, bigger babies and paediatric patients.

Results {#s3}
=======

A total of 1454 patients were admitted to the PNICU during the study period. Records could not be retrieved for 182 patients, so the study included 1272 patients. There were 292 VLBW babies (22.9%), 451 bigger babies (35.4%) and 529 paediatric (41.5%) admissions. The overall proportion dying was 25.7% (327/1272). There was a statistically significant difference in the proportion of deaths between patients of different ages, with the death rate being 41.4% (121/292) (95% CI 35.8% to 47.1%) in VLBW babies, 26.6% (120/451) (95% CI 22.5% to 30.5%) in bigger babies and 16.2% (86/529) (95% CI 13.1% to 19.3%) in paediatric patients (p\<0.0001).

Paediatric ICU admissions {#s3a}
-------------------------

Details of the 529 paediatric admissions are shown in [table 1](#BMJOPEN2015010850TB1){ref-type="table"}. The median age at admission was 8.7 months (IQR=46.5). There was no statistically significant difference in the median age of admissions between survivors and non-survivors (10.5 months (IQR=50.7) vs 7.3 months (IQR=35.7); p=0.412). Similarly, the median duration of ICU stay was not significantly different for survivors and non-survivors (∼3 days in both groups; p=0.540). The majority of patients (471/529; 89%) were intubated and ventilated. More than half (305/529; 57.7%) of the paediatric patients were surgical admissions. The most common problem in medical paediatric patients was lower respiratory tract illness (191/529; 36.1%).

###### 

Factors associated with survival in the 529 paediatric patients admitted to CMJAH PNICU between 1 January 2013 and 30 June 2015

  Variable                               Children with the condition (%)   Percentage of children with the condition that died (95% CI)   Percentage of children without the condition that died (95% CI)   p Value
  -------------------------------------- --------------------------------- -------------------------------------------------------------- ----------------------------------------------------------------- ---------
  Male                                   292 (55.2)                        16.1 (11.9 to 20.3)                                            17.4 (12.3 to 22.5)                                               0.477
  HIV exposed\*                          106 (20)                          30.2 (21.5 to 38.9)                                            12.2 (9.1 to 16.1)                                                \<0.001
  HIV PCR positive\*                     30 (5.7)                          30 (13.6 to 46.4)                                              15.4 (12.2 to 18.6)                                               0.036
  Recurrent admission                    52 (9.8)                          11.5 (2.8 to 20.1)                                             16.8 (13.4 to 20.2)                                               0.604
  Postcardiac arrest\*                   34 (6.4)                          47 (30.2 to 63.8)                                              13.4 (10.4 to 16.4)                                               \<0.001
  Intubated and ventilated               471 (89)                          17.2 (13.8 to 20.6)                                            8.6 (1.3 to 15.8)                                                 0.095
  Surgical patients\*                    305 (57.7)                         9.8 (6.3 to 13.3)                                             25.0 (19.3 to 30.7)                                               \<0.001
  Postoperative\*                        239 (45.2)                        7.5 (4.2 to 10.8)                                              23.6 (18.7 to 28.6)                                               \<0.001
  Trauma                                 75 (14.2)                         18.6 (9.8 to 27.4)                                             15.8 (12.4 to 19.2)                                               0.542
  Inotropic support\*                    53 (10.0)                         60.4 (47.2 to 73.6)                                            11.2 (8.3 to 14.1)                                                \<0.001
  Upper respiratory tract\*              61 (11.5)                         6.5 (0.3 to 12.7)                                              17.5 (14.6 to 20.9)                                               0.029
  Lower respiratory tract\*              191 (36.1)                        25.6 (19.4 to 31.8)                                            10.9 (7.6 to 14.2)                                                \<0.001
  Cardiovascular\*                       97 (18.3)                         28.9 (19.9 to 37.9)                                            13.4 (10.2 to 16.6)                                               \<0.001
  Neurological                           125 (23.6)                        22.5 (15.2 to 29.9)                                            16.7 (12.8 to 20.6)                                               0.086
  Gastrointestinal\*                     65 (12.3)                         26.1 (15.4 to 36.8)                                            14.9 (11.7 to 18.1)                                               0.021
  Renal\*                                18 (3.4)                          29.4 (6.3 to 52.5)                                             15.6 (12.5 to 18.8)                                               0.024
  Haematology/oncology (incl. anaemia)   108 (20.4)                        13.8 (7.3 to 20.3)                                             16.8 (13.2 to 20.4)                                               0.559
  Hypernatraemia\*                       15 (2.8)                          33.3 (9.5 to 15.2)                                             14.8 (11.7 to 17.9)                                               \<0.001
  Hyperglycaemia\*                       6 (1.1)                           50 (9.9 to 90.0)                                               15.8 (12.7 to 18.9)                                               0.024
  Hypoglycaemia\*                        11 (2.1)                          45.4 (15.9 to 74.8)                                            15.6 (12.7 to 18.7)                                               0.008
  Metabolic acidosis\*                   26 (4.9)                          46.2 (27.0 to 65.4)                                            14.7 (11.6 to 17.8)                                               \<0.001
  Poisoning                              17 (3.2)                          23.5 (3.3 to 43.7)                                             15.8 (12.6 to 19.0)                                               0.494
  Drowning                               7 (1.3)                           14.2 (11.7 to 40.1)                                            16.4 (13.2 to 19.6)                                               0.824
  Bacterial sepsis\*                     64 (12.1)                         32.8 (21.3 to 44.3)                                            13.7 (10.5 to 16.9)                                               \<0.001
  Viral infection                        34 (6.4)                          17.6 (4.8 to 30.4)                                             16.2 (12.9 to 19.5)                                               0.974
  Fungal infection                       16 (3.0)                          31 (8.3 to 51.7)                                               15.6 (12.4 to 18.8)                                               0.229

\*Statistically significant predictors of survival on univariate analysis.

CMJAH, Charlotte Maxeke Johannesburg Academic Hospital; PNICU, paediatric/neonatal intensive care unit.

Binary logistic regression analysis with survival to discharge from PNICU as the outcome variable showed that poor outcome was associated with postcardiac arrest (OR 0.21, 95% CI 0.09 to 0.49), inotropic support (OR 0.085, 95% CI 0.04 to 0.17), hypernatraemia (OR 0.16, 95% CI 0.04 to 0.6), bacterial sepsis (OR 0.32, 95% CI 0.16 to 0.65) and lower respiratory tract infection (OR 0.54, 95% CI 0.30 to 0.97). Postoperative patients were very unlikely to die during the PNICU admission (OR 2.96, 95% CI 1.49 to 5.92).

Bigger babies {#s3b}
-------------

Characteristics of the 451 bigger babies admitted to PNICU and factors associated with their survival to ICU discharge are shown in [table 2](#BMJOPEN2015010850TB2){ref-type="table"}. The median duration of ventilation for bigger babies was 3 days (IQR=75). The babies who died had a significantly shorter duration of ventilation compared with survivors (2 days (IQR=6) vs 4 days (IQR=6); p\<0.001). The mean gestational age of bigger babies admitted to PNICU was 36.97±3.6 weeks and mean birth weight was 2603±736 g. There were no statistically significant differences between survivors and non-survivors in gestational age (36.89±3.6 vs 37.23±3.5 weeks; p=0.404) or birth weight (2617±763 vs 2576±663 g; p=0.615). Binary logistic regression showed that birth weight did not influence survival in this subcategory (p=0.614). Just over one-third of bigger babies (34.3%) were surgical patients.

###### 

Characteristics and predictors of survival in 451 bigger babies admitted to CMJAH PNICU between 1 January 2013 and 30 June 2015

  Variable                            Children with the condition (%)   Percentage of babies with the condition that died (95% CI)   Percentage of babies without the condition that died (95% CI)   p Value
  ----------------------------------- --------------------------------- ------------------------------------------------------------ --------------------------------------------------------------- ---------
  *Place of birth*                                                                                                                                                                                   
  Another unit                        220 (48.7)                        34.1 (27.8 to 40.4)                                                                                                          0.577
  Born outside health facility        14 (3.1)                          28.6 (4.9 to 52.3)                                                                                                           
  CMJAH                               186 (41.2)                        30.1 (23.5 to 36.7)                                                                                                          
  Antenatal care                      302 (67)                          27.2 (22.2 to 32.2)                                          26.8 (18.0 to 35.6)                                             0.827
  Maternal HIV                        127 (28.2)                        32.3 (24.2-40.4)                                             24.9 (20.0-29.9)                                                0.231
  Caesarean section                   169 (37.4)                        23.6 (17.0 to 30.2)                                          32.9 (25.9 to 40.0)                                             0.31
  Male                                274 (60.8)                        27.7 (22.4 to 33.0)                                          25.3 (18.8 to 31.8)                                             0.491
  Resuscitated at birth               98 (21.7)                         28.6 (19.7 to 37.6)                                          26.1 (21.5 to 30.7)                                             0.619
  Early-onset sepsis                  20 (4.4)                          20 (2.5 to 37.5)                                             27.1 (22.8 to 31.4)                                             0.664
  Meconium aspiration                 75 (16.6)                         25.3 (15.5 to 35.1)                                          26.9 (22.4 to 31.4)                                             0.784
  Hyaline membrane disease\*          89 (19.7)                         16.9 (9.1 to 24.7)                                           29.0 (24.3 to 33.7)                                             0.02
  PPHN\*                              45 (10.0)                         46.7 (32.1 to 61.3)                                          24.4 (20.2 to 28.6)                                             0.002
  Surfactant therapy                  108 (23.9)                        21.3 (13.4 to 29.0)                                          28.7 (13.4 to 29.0)                                             0.518
  Hypotension requiring inotropes\*   55 (12.2)                         54.5 (41.3 to 67.7)                                          22.7 (18.6 to 26.8)                                             \<0.001
  CHD\*                               37 (8.2)                          54.1 (38.0 to 70.2)                                          25.3 (21.1 to 29.5)                                             \<0.001
  NEC                                 43 (9.5)                          37.2 (22.8 to 51.7)                                          25.3 (21.1 to 29.5)                                             0.35
  Surgery (excluding NEC)             129 (28.6)                        23.3 (16.0 to 30.6)                                          28.0 (23.1 to 32.9)                                             0.395
  Hyperglycaemia\*                    46 (10.2)                         41.3 (27.1 to 55.5)                                          24.9 (20.7 to 29.1)                                             0.017
  Metabolic acidosis\*                48 (10.6)                         56.3 (42.3 to 70.3)                                          23.1 (19.0 to 27.2)                                             \<0.001
  Late-onset sepsis                   119 (26.4)                        29.4 (21.2 to 37.6)                                          25.6 (20.9 to 30.3)                                             0.420
  Major birth defect\*                146 (32.4)                        36.3 (28.5 to 44.1)                                          22.0 (17.4 to 26.7)                                             0.002

\*Statistically significant predictors of survival on univariate analysis.

CHD, congenital heart disease; CMJAH, Charlotte Maxeke Johannesburg Academic Hospital; NEC, necrotising enterocolitis; PNICU, paediatric/neonatal intensive care unit; PPHN, persistent pulmonary hypertension of the neonate.

Binary logistic regression analysis for factors associated with survival in bigger babies showed major birth defects (OR 0.44, 95% CI 0.26 to 0.74), persistent pulmonary hypertension of the neonate (PPHN) (OR 0.44, 95% CI 0.21 to 0.91), metabolic acidosis (OR 0.23, 95% CI 0.12 to 0.74), inotropic support (OR 0.23, 95% CI 0.12 to 0.45) and congenital heart disease (CHD) (OR 0.29, 95% CI 0.13 to 0.62), all predictive of poor survival.

VLBW babies {#s3c}
-----------

Characteristics of the 292 VLBW babies admitted to the PNICU are shown in [table 3](#BMJOPEN2015010850TB3){ref-type="table"}. The mean birth weight was 1133.2±182 g and mean gestational age 28.95±8.17 weeks. There were no statistically significant differences between survivors and non-survivors in mean birth weight (1149±182 vs 1109±180 g; p=0.063) or gestational age (29.01±2.1 vs 28.86±2.1 weeks; p=0.540). The median duration of ventilation was 5 days (IQR=8). The duration of ventilation was significantly shorter in VLBW babies who died (4 days (IQR=10) vs 6 days (IQR=7); p\<0.001).

###### 

Characteristics and predictors of survival for 292 VLBW babies admitted to the CMJAH PNICU between 1 January 2013 and 30 June 2015

  Variable                       Babies with the condition (%)   Percentage of babies with the condition that died (95% CI)   Percentage of babies without the condition that died (95% CI)   p Value
  ------------------------------ ------------------------------- ------------------------------------------------------------ --------------------------------------------------------------- ---------
  *Place of birth*\*                                                                                                                                                                          
  Born outside health facility   19 (6.5)                        68.4 (47.5 to 89.3)                                                                                                          0.008
  Born at another unit           97 (33.2)                       32.0 (22.7 to 41.3)                                                                                                          
  Born at CMJAH                  176 (60.3)                      43.8 (36.5 to 51.1)                                                                                                          
  Antenatal care                 171 (58.6)                      39.8 (32.5 to 47.1)                                          43.8 (35.0 to 52.6)                                             0.49
  Antenatal steroids             86 (29.5)                       43.0 (32.5 to 53.5)                                          40.8 (34.1 to 47.5)                                             0.722
  Maternal HIV                   98 (33.6)                       49.0 (39.1 to 58.9)                                          37.6 (30.8 to 44.4)                                             0.063
  Caesarean section              124 (42.5)                      39.5 (30.9 to 48.1)                                          44.2 (35.7 to 52.7)                                             0.817
  Male                           164 (56.2)                      42.7 (35.1 to 50.3)                                          40.2 (31.7 to 48.7)                                             0.638
  Resuscitated at birth          112 (38.4)                      50.9 (41.6 to 60.2)                                          35.6 (28.6 to 42.6)                                             0.099
  Early-onset sepsis             10 (3.4)                        60 (29.6 to 90.4)                                            39.8 (33.9 to 45.7)                                             0.358
  IVH ¾\*                        32 (10.9)                       53.1 (35.8 to 70.4)                                          33.3 (26.6 to 40.0)                                             \<0.001
  Hyaline membrane disease       268 (91.8)                      41.4 (35.5 to 47.3)                                          41.6 (21.9 to 61.3)                                             0.981
  Surfactant                     228 (78.1)                      39.9 (33.5 to 46.3)                                          46.9 (34.7 to 59.1)                                             0.318
  Patent ductus arteriosus\*     83 (28.4)                       26.5 (17.0 to 36.0)                                          47.3 (40.5 to 54.1)                                             \<0.001
  NEC\*                          72 (24.7)                       62.5 (51.3 to 73.7)                                          34.5 (28.2 to 40.8)                                             \<0.001
  NEC surgery\*                  39 (13.4)                       56.4 (40.8 to 72.0)                                          39.1 (33.1 to 45.1)                                             0.041
  Other surgery                  36 (12.3)                       50 (33.7 to 66.3)                                            40.2 (34.2 to 46.2)                                             0.265
  Blood transfusion              88 (30.1)                       38.7 (32.0 to 45.4)                                          47.7 (37.3 to 58.1)                                             0.152
  Hyperglycaemia                 68 (22.3)                       51.5 (39.6 to 63.4)                                          38.4 (32.0 to 44.8)                                             0.055
  Hypoglycaemia                  38 (13.0)                       42.1 (26.4 to 57.8)                                          41.3 (35.2 to 47.4)                                             0.929
  Hypernatraemia                 22 (7.5)                        40.9 (20.4 to 61.4)                                          41.5 (35.6 to 47.4)                                             0.958
  Metabolic acidosis\*           39 (13.4)                       19.2 (54.7 to 83.7)                                          37.2 (31.2 to 43.2)                                             \<0.001
  Late-onset sepsis              142 (48.6)                      39.3 (31.5 to 47.1)                                          43.7 (35.5 to 51.9)                                             0.453
  Major birth defect             19 (6.5)                        42.1 (19.9 to 64.3)                                          41.4 (36.4 to 46.4)                                             0.951

\*Statistically significant predictors of survival on univariate analysis.

CMJAH, Charlotte Maxeke Johannesburg Academic Hospital; IVH, intraventricular haemorrhage; NEC, necrotising enterocolitis; PNICU, paediatric/neonatal intensive care unit.

Binary logistic regression showed that the following factors were associated with reduced survival in VLBW babies: birth weight (OR 0.997, 95% CI 0.995 to 0.999), born before arrival (OR 0.21, 95% CI 0.05 to 0.84), maternal HIV exposure (OR 0.54, 95% CI 0.30 to 0.99), resuscitation at birth (OR 0.49, 95% CI 0.25 to 0.94), metabolic acidosis (OR 0.25, 95% CI 0.10 to 0.60) and necrotising enterocolitis (NEC) (OR 0.23, 95% CI 0.12 to 0.46).

Discussion {#s4}
==========

This review of admissions to a combined PNICU shows an overall mortality rate of 25.7%. The paediatric mortality rate was 16.2%. This is higher than the mortality rate at the dedicated paediatric ICU at RCWMCH[@R4] but lower than that reported for children admitted to general ICUs in other African countries.[@R8]

Possible reasons for the high mortality rate in this study may lie outside the PNICU, such as late referral and inadequate resuscitation, or within, such as insufficient beds and inadequate staffing. The lack of a paediatric intensivist may partly contribute to the mortality rate; dedicated paediatric intensivists have been shown to reduce the mortality rate of children in ICU and improve bed utilisation.[@R17] This PNICU was run mainly as an invasive ventilator unit, with limited high-dependency care admissions; 89% of the paediatric patients and all neonates admitted to PNICU were intubated and ventilated. Therefore, this may represent a sicker cohort of children compared with other PICUs. Mortality prediction risk scores such as the Paediatric Index of Mortality (PIM) allow objective comparisons between different units.[@R18] Although PIM data were not collected during the study period, the predictors of poor outcome in the current study were similar to the PIM, including postcardiac arrest, inotropic support and metabolic acidosis.

The mortality was higher in neonates than paediatric patients. Mortality of ventilated neonates was similar to that reported from units in India.[@R19] The very high mortality of the VLBW group in the PNICU is not surprising as these patients had failed initial NCPAP and were therefore very sick babies. The mortality rate of ventilated VLBW infants was similar to that reported in a study in China.[@R20] Birth weight, the strongest predictor of outcome in VLBW infants in our setting,[@R21] remained a significant factor associated with survival in the ventilated VLBW babies.

HIV infection and HIV exposure were significant predictors of outcome in the univariate analysis, but not in the logistic regression. There is, however, selection bias, as only those HIV-exposed infants who were expected to recover were admitted to the PNICU.

Other potential sources of bias were considered. The age of paediatric patients was skewed towards younger children who would be expected to have a higher mortality than their older counterparts. There was a slight preponderance of infants (\<1 year of age) in the paediatric age group (274/529 (51.8%)). However, there was no significant difference in the number of deaths between infants and older children (53/274 (19.3%) vs 33/245 (13.5%) p=0.077). Similarly, neonates weighing \>2500 g are expected to have a different disease profile and mortality rate from those weighing \<2500 g. Babies \>2500 g could therefore have been another source of bias in the category of bigger babies; however, binary logistic regression showed that birth weight did not influence survival in this category (p=0.614).

There were some apparent anomalies in our data. The low incidence of viral infections and hyperglycaemia may reflect lack of active surveillance for these conditions. The low number of fungal isolates may be explained by the fact that fungal organisms are difficult to isolate on paediatric low-volume blood cultures.

This study raises the issue of children\'s rights to healthcare. A report from 2007 showed that only 19.6% of the ICU beds in South Africa are dedicated to the care of children.[@R13] Our study raises the issue of balancing the rights of older children against those of neonates in a combined PNICU. Only the very sickest neonates (those who failed NCPAP) were admitted to the PNICU, which may be a form of discrimination. There are no easy ways to identify which patients to admit to PNICU, especially in a resource-limited setting.[@R2] [@R4] Children must not come to ICU to die, yet many who are critically ill, with an increased risk of death, may have a better chance of recovery if treated in ICU. We found that postoperative patients had good outcomes, which may reflect the optimal use of ventilator beds in this unit, or may indicate that many of these patients did not require ICU. Increasing the number of 'high-care' admissions would decrease the PNICU mortality rate, but this would often be at the expense of a sicker child requiring ventilation.

This study had several limitations. The raw proportion of deaths in the CMJAH PNICU is higher than other units but may reflect a different level of severity of illness. As may be the case with retrospective analyses, not all information was available for inclusion in the study. The use of a standardised illness code such as the Australian and New Zealand practice in intensive care (ANZPIC) system may have been preferable.[@R22]

Conclusions and recommendations {#s5}
===============================

The unadjusted mortality rate of children admitted to this combined PNICU is higher than that reported in a dedicated PICU in the same country.[@R4] Incorporation of a paediatric intensivist, even in poorer countries, improves the outcome for children, both in terms of mortality and length of stay.[@R11] [@R17] Ongoing training in the stabilisation and management of critically ill children is essential for all paediatric registrars, general paediatricians and other subspecialists. Future clinical audits should include a severity of illness score such as the PIM,[@R22] hospital paediatric mortality rate and the number of children denied admission to PNICU, together with outcome data.
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